MarketWatch

Dana Brata Luhur

Dana Brata Luhur Annual stock financials by MarketWatch. View the latest TEBE financial statements, income statements and financial ratios.
Investing

Dana Brata Luhur Stock Price History

Dana Brata Luhur (TEBE) has delivered a 99% change over the past year, with a 52-week range between 605 and 4,530. What Is the Average Daily Trading Volume of Dana Brata Luhur (TEBE)? The average ...
Yahoo Finance

PT Dana Brata Luhur Tbk (TEBE.JK)

Select to analyze similar companies using key performance metrics; select up to 4 stocks.
ascopubs.org

Updated overall survival (OS) data from the phase 1b study of tebentafusp (tebe) as monotherapy or combination therapy with durvalumab (durva) and/or tremelimumab (treme) in ...

Circulating tumor DNA (ctDNA) and late recurrence in high-risk, hormone receptor–positive, HER2-negative breast cancer (CHiRP). This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I.
ascopubs.org

Co-primary endpoint of overall survival for tebentafusp (tebe)-induced rash in a phase 3 randomized trial comparing tebe versus investigator’s choice (IC) in first-line ...

Overall survival in patients who received checkpoint inhibitors after completing tebentafusp in a phase 3 randomized trial of first-line metastatic uveal melanoma. This is an ASCO Meeting Abstract ...
Hosted on MSN

Viaggio a Tebe, la grande capitale dei faraoni

Sebbene la storia di Tebe abbia radici molto antiche, la sua ascesa alla ribalta nella storia dell'antico Egitto avvenne a metà del II millennio a.C., sotto la nuova XVIII dinastia. I suoi fondatori ...